Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease
- PMID:17997269
- DOI: 10.1016/j.jvs.2007.08.050
Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease
Abstract
Objective: To compare late patency after direct and crossover bypass in good-risk patients with unilateral iliac occlusive disease not amenable to angioplasty.
Methods: Between May 1986 and March 1991, 143 patients with unilateral iliac artery occlusive disease and disabling claudication were randomized into two surgical treatment groups, ie, crossover bypass (n = 74) or direct bypass (n = 69). The size of the patient population was calculated to allow detection of a possible 20% difference in patency in favor of direct bypass with a one-sided alpha risk of 0.05 and a beta risk of 0.10. Patients underwent yearly follow-up examinations using color flow duplex scanning with ankle-brachial systolic pressure index measurement. Digital angiography was performed if hemodynamic abnormalities were noted. Median follow-up was 7.4 years. Primary endpoints were primary patency and assisted primary patency estimated by the Kaplan-Meier method with 95% confidence interval. Secondary endpoints were secondary patency and postoperative mortality and morbidity.
Results: Cardiovascular risk factors, preoperative symptoms, iliac lesions TASC class (C in 87 [61%] patients and D in 56 [39%] patients), and superficial femoral artery (SFA) run-off were comparable in the two treatment groups. One patient in the direct bypass group died postoperatively. Primary patency at 5 years was higher in the direct bypass group than in the crossover bypass group (92.7 +/- 6.1% vs 73.2 +/- 10%, P = .001). Assisted primary patency and secondary patency at 5 years were also higher after direct bypass than crossover bypass (92.7 +/- 6.1% vs 84.3 +/- 8.5%, P = .04 and 97.0 +/- 3.0% vs 89.8 +/- 7.1%, P = .03, respectively). Patency at 5 years after crossover bypass was significantly higher in patients presenting no or low-grade SFA stenosis than in patients presenting high-grade (> or =50%) stenosis or occlusion of the SFA (74.0 +/- 12% vs 62.5 +/- 19%, P = .04). In both treatment groups, patency was comparable using polytetrafluoroethylene (PTFE) and polyester grafts. Overall survival was 59.5 +/- 12% at 10 years.
Conclusion: This study showed that late patency was higher after direct bypass than crossover bypass in good-risk patients with unilateral iliac occlusive disease not amenable to angioplasty. Crossover bypass should be reserved for high-risk patients with unilateral iliac occlusion not amenable to percutaneous recanalization.
Similar articles
- Is femorofemoral crossover bypass an option in claudication?Capoccia L, Riambau V, da Rocha M.Capoccia L, et al.Ann Vasc Surg. 2010 Aug;24(6):828-32. doi: 10.1016/j.avsg.2010.03.021.Ann Vasc Surg. 2010.PMID:20638622Review.
- Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease.Dosluoglu HH, Cherr GS, Lall P, Harris LM, Dryjski ML.Dosluoglu HH, et al.J Vasc Surg. 2008 Nov;48(5):1166-74. doi: 10.1016/j.jvs.2008.06.006. Epub 2008 Aug 9.J Vasc Surg. 2008.PMID:18692357
- [Factors determining late patency of aortobifemoral bypass graft].Davidović LB, Lotina SI, Kostić DM, Cinara II, Cvetković SD, Stojanov PL, Velimirović DB, Marković MM, Pejkić SA, Vukotić AM.Davidović LB, et al.Srp Arh Celok Lek. 1997 Jan-Feb;125(1-2):24-35.Srp Arh Celok Lek. 1997.PMID:17974352Serbian.
- Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.McQuade K, Gable D, Hohman S, Pearl G, Theune B.McQuade K, et al.J Vasc Surg. 2009 Jan;49(1):109-15, 116.e1-9; discussion 116. doi: 10.1016/j.jvs.2008.08.041. Epub 2008 Nov 22.J Vasc Surg. 2009.PMID:19028055Clinical Trial.
- Femorofemoral bypass graft: analysis of patency and factors influencing long-term outcome.Criado E, Burnham SJ, Tinsley EA Jr, Johnson G Jr, Keagy BA.Criado E, et al.J Vasc Surg. 1993 Sep;18(3):495-504; discussion 504-5.J Vasc Surg. 1993.PMID:8377244Review.
Cited by
- Gender-specific risk factors for peripheral artery disease in a voluntary screening population.Hiramoto JS, Katz R, Weisman S, Conte M.Hiramoto JS, et al.J Am Heart Assoc. 2014 Mar 13;3(2):e000651. doi: 10.1161/JAHA.113.000651.J Am Heart Assoc. 2014.PMID:24627420Free PMC article.
- Global vascular guidelines on the management of chronic limb-threatening ischemia.Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, Mills JL, Ricco JB, Suresh KR, Murad MH; GVG Writing Group.Conte MS, et al.J Vasc Surg. 2019 Jun;69(6S):3S-125S.e40. doi: 10.1016/j.jvs.2019.02.016. Epub 2019 May 28.J Vasc Surg. 2019.PMID:31159978Free PMC article.
- [Occlusion of the aorta and iliac arteries].Kosan J, Riess H, Atlihan G, Diener H, Kölbel T, Debus ES.Kosan J, et al.Chirurg. 2014 Sep;85(9):791-9. doi: 10.1007/s00104-014-2720-3.Chirurg. 2014.PMID:25182006Review.German.
- Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia.Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, Mills JL, Ricco JB, Suresh KR, Murad MH, Aboyans V, Aksoy M, Alexandrescu VA, Armstrong D, Azuma N, Belch J, Bergoeing M, Bjorck M, Chakfé N, Cheng S, Dawson J, Debus ES, Dueck A, Duval S, Eckstein HH, Ferraresi R, Gambhir R, Gargiulo M, Geraghty P, Goode S, Gray B, Guo W, Gupta PC, Hinchliffe R, Jetty P, Komori K, Lavery L, Liang W, Lookstein R, Menard M, Misra S, Miyata T, Moneta G, Munoa Prado JA, Munoz A, Paolini JE, Patel M, Pomposelli F, Powell R, Robless P, Rogers L, Schanzer A, Schneider P, Taylor S, De Ceniga MV, Veller M, Vermassen F, Wang J, Wang S; GVG Writing Group for the Joint Guidelines of the Society for Vascular Surgery (SVS), European Society for Vascular Surgery (ESVS), and World Federation of Vascular Societies (WFVS).Conte MS, et al.Eur J Vasc Endovasc Surg. 2019 Jul;58(1S):S1-S109.e33. doi: 10.1016/j.ejvs.2019.05.006. Epub 2019 Jun 8.Eur J Vasc Endovasc Surg. 2019.PMID:31182334Free PMC article.
- Neointimal hyperplasia after stent placement across size-discrepant vessels in an animal study.Cho H, Nango M, Sakai Y, Sohgawa E, Kageyama K, Hamamoto S, Kitayama T, Yamamoto A, Miki Y.Cho H, et al.Jpn J Radiol. 2014 Jun;32(6):340-6. doi: 10.1007/s11604-014-0311-3. Epub 2014 Apr 9.Jpn J Radiol. 2014.PMID:24715330
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources